NEW YORK, June 28, 2017 /PRNewswire/ -- Blink Health, America's leading prescription drug savings platform, recently launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of diabetes medications. People living with diabetes who create an account on Blink Health's website or free mobile app, starting today, will receive a free, one-year supply of the three most commonly prescribed generic medications for type-2 diabetes: metformin, glipizide and pioglitazone. The program will also cover these three medications for existing Blink Health patients who use them.

To create an account, visit the Blink Health. website: https://www.blinkhealth.com/diabetes.

Diabetes in America
As part of Blink Health's ongoing commitment to support people who are living with diabetes, the #TreatType2program is designed to help the largest population of people managing this condition. Of the nearly 29 million Americans with diabetes, approximately 95 percent have been diagnosed with type 2. Tragically, African Americans are 77 percent more likely to be diagnosed with diabetes than non-Hispanic Caucasians, according to the US Department of Health & Human Resources. This $10 million giveaway represents a potential savings of up to $4,000 per patient, per year, for someone who's taking all three medications and paying the full retail price out of pocket, either because they are uninsured or have a high-deductible insurance plan.

Who is Eligible?
Blink Health will provide the free medications to everyone until it has committed to spending $10 million on the medications. Any patient with a prescription for any or all of these three medications is eligible to receive medication for free. There is no cost to join Blink Health, and medication can be picked up at over 57,000 pharmacies nationwide, including Walmart, CVS, Rite-Aid, Target, and most independent pharmacies and grocers. Blink Health helps consumers save on the cost of generic medications – the most common ones prescribed – by negotiating low prices directly with manufacturers.

"Overall, diabetes is a growing epidemic that affects 1 in 11 Americans, and Blink Health is committed to doing all it can to help patients manage this chronic illness," said Geoffrey Chaiken, Co-Founder and CEO of Blink Health. "We have seen far too many people who are struggling to afford prescription medication, and we've launched this program to help address the problem one patient at a time."

Information About Discounted Insulin Available Through Blink Health 
Blink Health is also working on solutions to lower the price of insulin. Blink Health and Eli Lilly and Company (NYSE: LLY) have entered into a first-of-its-kind access program to offer a 40 percent discount on Lilly insulins, including Humalog, one of the most widely prescribed branded insulin medications.

Follow us on Facebook and Twitter.

SOURCE Blink Health:
http://www.blinkhealth.com